Dial-in Number

  • One tap mobile
    +13126266799,,3231998494# US (Chicago)
    +13462487799,,3231998494# US (Houston)
  • Dial by your location
    +1 312 626 6799 US (Chicago)
    +1 346 248 7799 US (Houston)
    +1 669 900 6833 US (San Jose)
    +1 929 436 2866 US (New York)
    +1 253 215 8782 US
    +1 301 715 8592 US
    Meeting ID: 323 199 8494
    Find your local number:

Web session

HL7 Antitrust Policy

Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).


Please include your organization in your Zoom name.

  • Click on your picture/name in Zoom
  • Click on rename
  • enter <name> - <organization>
Jean Duteau (chair)Duteau Designx
John Hatem Independent Consultant
Jose Costa Teixeira PATHx
Melva PetersJenaker Consulting
Scott Robertson (scribe)Kaiser Permanentex

Danielle BancroftBest Practice Software
Christof GessnerHL7 Germany
Corey SpearsMITRE
Dave HillMITRE
Frank McKinneyPOCPx
Isaac VetterEpic
Smile Digital Health
Lawrence LoColumbia University HIT Student
Margaret WeikerNCPDPx
Matt SzczepankiewiczEpic
Peter SergentHL7 New Zealand
Reed D. GelzerTrustworthy EHR
Shelly SpiroPharmacy HIT Collaborativex
Stephen ChuADHAx
Tim McNeilSurescripts
Kim RobertsPharmacy HIT Collaborative
Phung Matthews3M
Jack BrashierEpic
Emmanuel Obasuyi

Joel MontavonPQA
Robb YoungPharmID
Christopher Isong

Gary SchoettmerNetRx
Courtney BlandCVS / Aetna
Mark NeumuthAetna
Ed MillikanFDA
Sanket RavalCVS / Aetna
James Tcheng

Peter Muir

Joe KellySurescriptsx
Peter Jordan

Giorgio CangioliHL7 Italyx
Jeff ShickUSP
Kent BulzaArtera
Sarah Danielson

Hans Buitendijk
Pooja BabbrahPOCPx

Agenda Items and Notes

Outstanding Action Item List

Meeting Notes from the previous meeting

  • 2023-03-13 Meeting Notes  - accepted by acclimation

Project Proposals

Project Proposals in Review - none to review

Project Scope Statements

Project Scope Statements - none to review

May WGM Draft Agenda Review

  • - skipped

External Meeting Review

  • - nothing to report

Catalog Updates (John Hatem)

  • - No meeting last week

Workflow Update (John Hatem)

  •   - No update

Healthcare Product Update (John Hatem)

  • - No update

EHR conformant reconciled medication list (cRML) (Scott Robertson / John Hatem / Jimmy Tcheng)

  • - No meeting this week, next meeting will be the first week of April. 

Project updates

Pharmacy Templates

Trackers - Pharmacy Tracker Dashboard (see trackers for details / resolutions)

  • - in good shape.  a number of things require input/work from other groups.  remaining items are minor 

Status state diagram review 

  • John reviewed the mapping between Med dispense status and BDP dispense status.  Suggestion was to send this to the list serve for input. 
    • review of mapping document.  
      • "ready for pickup" (in pharmacy) compares to "allocated" in BDP.
        • BDP "allocated" description is "ready for transport"   
      • "returned" - we don't have it, do we need it (returned after picked up).  usually these are wasted ... but can be reused in some cases. 
        • as opposed to "return to stock," which was "ready for pickup" and not received by patient.
      • pharmacy "completed" - BDP says "issued"
      • pharmacy "stopped" ("failed") - BDP uses "unfulfilled".
      • pharmacy "declined" ("not-done) - maybe BDP "returned" ("abandoned")
    • - Need status update? 
      • John's working on it

NCPDP Updates (NCPDP Members)

Specialty Medication Enrolment IG

  • - Need status update - have all items below been completed? 

Any Other Business

  • USCDI - Shelly Spiro / Hans Buitendijk
    • discuss USCDI during call today - dedicate about 30 minutes for the discussion. ( Scott reached out to Hans for overview - awaiting his response)  also invite Margaret (for NCPDP side).  send note to list
      • Hans present.  extended discussion on what USCDI is, what the current (v4) goal is, how are terms defined.
        • USCDI is a set of data elements which are required for the certification of HIT systems.  currently that means that all HIT systems must be able to support all USCDI elements, even those that do not pertain to specific scenarios.  for example, Lab systems may not care about past procedures or medication instructions, but certification to USCDI would require lab systems support that information (e.g., store if received, send if present).  Comments have been submitted to the regulatory process to provide flexibility to not require all USCDI elements for all systems.
      • Medication Instructions - information to patient or care giver on how to take the medication (dose, interval, etc.).  added in v4.  Note this will initially just be a text string, but in the future should/could be fully encoded.  Maps to MedicationRequest.dosageInstruction.text (FHIR US Core v5) and MedicationDispense..dosageInstruction.text (FHIR US Core v5).
      • Medication Administration - record of mediation administrated to the patient.  mostly for inpatient and clinic-administered meds.  unlikely to be available for retail prescriptions.  group is intereste in promoting to include in v4
      • Quantity - the number of (doses) in a dispense.  As opposed to the number of dosage units in each administration.  (smr - I know we discussed this but I can't find it in USCDI).  
  • Email from Floyd - pharmacy SIG questions

Next meeting: